39015037|t|Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta.
39015037|a|INTRODUCTION: Aging is one of the risk factors for the early onset of Alzheimer's disease (AD). We previously discovered that the age-dependent increase in Ubiquitin Conjugating Enzyme E2 N (UBE2N) plays a role in the accumulation of misfolded proteins through K63 ubiquitination, which has been linked to AD pathogenesis. However, the impact of UBE2N on amyloid pathology and clearance has remained unknown. RESULTS: We observed the elevated UBE2N during the amyloid beta (Abeta) generation in the brains of 5xFAD, APP/PS1 mice, and patients with AD, in comparison to healthy individuals. UBE2N overexpression exacerbated amyloid deposition in 5xFAD mice and senescent monkeys, whereas knocking down UBE2N via CRISPR/Cas9 reduced Abeta generation and cognitive deficiency. Moreover, pharmacological inhibition of UBE2N ameliorated Abeta pathology and subsequent transcript defects in 5xFAD mice. DISCUSSION: We have discovered that age-dependent expression of UBE2N is a critical regulator of AD pathology. Our findings suggest that UBE2N could serve as a potential pharmacological target for the advancement of AD therapeutics. HIGHLIGHTS: Ubiquitin Conjugating Enzyme E2 N (UBE2N) level was elevated during amyloid beta (Abeta) deposition in AD mouse and patients' brains. UBE2N exacerbated Abeta generation in the AD mouse and senescent monkey. Drug inhibition of UBE2N ameliorated Abeta pathology and cognitive deficiency.
39015037	12	17	UBE2N	Gene	93765
39015037	30	49	Alzheimer's disease	Disease	MESH:D000544
39015037	85	97	amyloid beta	Gene	351
39015037	169	188	Alzheimer's disease	Disease	MESH:D000544
39015037	190	192	AD	Disease	MESH:D000544
39015037	255	288	Ubiquitin Conjugating Enzyme E2 N	Gene	93765
39015037	290	295	UBE2N	Gene	93765
39015037	405	407	AD	Disease	MESH:D000544
39015037	445	450	UBE2N	Gene	7334
39015037	454	461	amyloid	Disease	MESH:C000718787
39015037	542	547	UBE2N	Gene	93765
39015037	559	571	amyloid beta	Gene	351
39015037	573	578	Abeta	Gene	11820
39015037	608	613	5xFAD	Disease	
39015037	619	622	PS1	Gene	338399
39015037	623	627	mice	Species	10090
39015037	633	641	patients	Species	9606
39015037	647	649	AD	Disease	MESH:D000544
39015037	689	694	UBE2N	Gene	93765
39015037	722	740	amyloid deposition	Disease	MESH:D058225
39015037	744	749	5xFAD	Disease	
39015037	750	754	mice	Species	10090
39015037	769	776	monkeys	Species	9527
39015037	800	805	UBE2N	Gene	93765
39015037	830	835	Abeta	Gene	11820
39015037	851	871	cognitive deficiency	Disease	MESH:D003072
39015037	913	918	UBE2N	Gene	93765
39015037	931	936	Abeta	Gene	11820
39015037	984	989	5xFAD	Disease	
39015037	990	994	mice	Species	10090
39015037	1060	1065	UBE2N	Gene	93765
39015037	1093	1095	AD	Disease	MESH:D000544
39015037	1133	1138	UBE2N	Gene	93765
39015037	1212	1214	AD	Disease	MESH:D000544
39015037	1241	1274	Ubiquitin Conjugating Enzyme E2 N	Gene	93765
39015037	1276	1281	UBE2N	Gene	93765
39015037	1309	1321	amyloid beta	Gene	351
39015037	1323	1328	Abeta	Gene	351
39015037	1344	1346	AD	Disease	MESH:D000544
39015037	1347	1352	mouse	Species	10090
39015037	1357	1365	patients	Species	9606
39015037	1375	1380	UBE2N	Gene	93765
39015037	1393	1398	Abeta	Gene	11820
39015037	1417	1419	AD	Disease	MESH:D000544
39015037	1420	1425	mouse	Species	10090
39015037	1440	1446	monkey	Species	9527
39015037	1467	1472	UBE2N	Gene	93765
39015037	1485	1490	Abeta	Gene	11820
39015037	1505	1525	cognitive deficiency	Disease	MESH:D003072
39015037	Association	MESH:D003072	93765
39015037	Association	MESH:D000544	11820
39015037	Positive_Correlation	351	93765
39015037	Association	MESH:D000544	93765
39015037	Positive_Correlation	MESH:D058225	93765
39015037	Positive_Correlation	11820	93765

